PREPROPOSAL STATEMENT OF INQUIRY
DEPARTMENT OF HEALTH
[Filed January 27, 2021, 1:14 p.m.]
This memo serves as notice that the pharmacy quality assurance commission (commission) is withdrawing the CR-101 for a new section in chapter 246-945 WAC, in which the commission was considering adopting a new section of rule to create criteria for a waiver for electronic prescribing as required by SSB 5380 (section 16, chapter 314, Laws of 2019). The CR-101 was filed on January 6, 2020, and published in WSR 20-03-020.
The commission is withdrawing this CR-101 because we received guidance on some procedural aspects of this rule that require us to refile the CR-101 paperwork. We are refiling this as a joint rule-making project to clarify that the commission and the department of health both have rule-making authority on this topic.
Individuals requiring information on this rule should contact Cori Tarzwell, policy analyst, at email@example.com; or Lindsay Trant, rules consultant, at firstname.lastname@example.org.
Tami M. Thompson
Regulatory Affairs Manager